NM_002520.7:c.524+334G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002520.7(NPM1):c.524+334G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.601 in 151,994 control chromosomes in the GnomAD database, including 27,806 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.60 ( 27806 hom., cov: 32)
Consequence
NPM1
NM_002520.7 intron
NM_002520.7 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.524
Publications
8 publications found
Genes affected
NPM1 (HGNC:7910): (nucleophosmin 1) The protein encoded by this gene is involved in several cellular processes, including centrosome duplication, protein chaperoning, and cell proliferation. The encoded phosphoprotein shuttles between the nucleolus, nucleus, and cytoplasm, chaperoning ribosomal proteins and core histones from the nucleus to the cytoplasm. This protein is also known to sequester the tumor suppressor ARF in the nucleolus, protecting it from degradation until it is needed. Mutations in this gene are associated with acute myeloid leukemia. Dozens of pseudogenes of this gene have been identified. [provided by RefSeq, Aug 2017]
NPM1 Gene-Disease associations (from GenCC):
- dyskeratosis congenitaInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.708 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NPM1 | NM_002520.7 | c.524+334G>A | intron_variant | Intron 6 of 10 | ENST00000296930.10 | NP_002511.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.600 AC: 91198AN: 151878Hom.: 27766 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
91198
AN:
151878
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.601 AC: 91292AN: 151994Hom.: 27806 Cov.: 32 AF XY: 0.597 AC XY: 44329AN XY: 74272 show subpopulations
GnomAD4 genome
AF:
AC:
91292
AN:
151994
Hom.:
Cov.:
32
AF XY:
AC XY:
44329
AN XY:
74272
show subpopulations
African (AFR)
AF:
AC:
29637
AN:
41442
American (AMR)
AF:
AC:
8254
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
2115
AN:
3472
East Asian (EAS)
AF:
AC:
2845
AN:
5168
South Asian (SAS)
AF:
AC:
2815
AN:
4814
European-Finnish (FIN)
AF:
AC:
5733
AN:
10550
Middle Eastern (MID)
AF:
AC:
185
AN:
294
European-Non Finnish (NFE)
AF:
AC:
37811
AN:
67966
Other (OTH)
AF:
AC:
1278
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1872
3744
5616
7488
9360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
758
1516
2274
3032
3790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1878
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.